Who is Robin Washington and what is her relevant experience?

Robin Washington is nominated for election to the Honeywell Board. She is currently the Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., a prominent biopharmaceutical company. This role suggests extensive experience in financial management, strategic planning, and corporate governance.

What is the significance of Ms. Washington's potential role on the Audit and Retirement Plans Committees?

Serving on the Audit Committee signifies her involvement in overseeing the company's financial reporting, internal controls, and risk management processes. Her potential role on the Retirement Plans Committee indicates a focus on employee benefit plans, which is a key aspect of corporate responsibility and financial planning.

When will the election of the new director take place?

The election of Ms. Washington, if she is to join the board, will occur at Honeywell's Annual Shareowner Meeting, scheduled for April 22, 2013.

Is this a significant change for Honeywell's board?

The addition of a new director with significant financial leadership experience from another major public company is generally considered a positive development for corporate governance. It indicates a proactive approach to refreshing board expertise and ensuring robust oversight.

HON/HONIV 8-K SEC Disclosure

Summary

Honeywell International Inc. (HON) filed an 8-K on March 1, 2013, to announce a significant change in its Board of Directors composition. Robin Washington, currently the Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., has been nominated for election to Honeywell's Board. If elected at the April 22, 2013 annual meeting of shareholders, Ms. Washington will bring her financial expertise to the Audit and Retirement Plans Committees. This nomination suggests Honeywell's ongoing commitment to strengthening its corporate governance and leveraging external financial leadership. Investors should note Ms. Washington's background at a prominent biopharmaceutical company, which may offer diverse perspectives to the board's decision-making processes, particularly concerning financial oversight and strategic planning. The election of Ms. Washington is a key event for shareholders to consider regarding the company's leadership and governance structure.

Key Highlights

1Nomination of Robin Washington, SVP & CFO of Gilead Sciences, Inc., to the Honeywell Board of Directors.
2Ms. Washington is nominated for election at the Annual Shareowner Meeting on April 22, 2013.
3If elected, Ms. Washington will serve on the Audit and Retirement Plans Committees.
4This filing indicates a planned addition to the company's board, potentially enhancing financial oversight and governance.
5The press release detailing this nomination is attached as Exhibit 99.1.

HONEYWELL INTERNATIONAL INC 8-K Report, Corporate Update (Mar 1, 2013)

Summary

Key Highlights

Frequently Asked Questions